Home » Topics » BioWorld Science

BioWorld Science
RSS

Intrathecal AVXS-301 shows promise in preclinical models of ALS

Dec. 11, 2019

FDA clears IND application for first-in-human study of CPT-31

Dec. 11, 2019

IND for HLX-10 plus HLX-07 antibody combination therapy approved in China

Dec. 11, 2019

Scohia Pharma initiates phase I study of SCO-267

Dec. 11, 2019

CARsgen Therapeutics receives IND clearance for AB-011 in China

Dec. 11, 2019

Enterovirus contributes to islet autoimmunity

Dec. 11, 2019

Killer T cells protected by membrane lipid order and charge

Dec. 11, 2019

Orca opens phase Ib study of TregGraft in hematologic malignancies

Dec. 10, 2019

Sinovent studies small-molecule human URAT1 inhibitor XNW-3009 in phase I

Dec. 10, 2019

FDA removes clinical hold on Abeona's phase III VIITAL study of EB-101

Dec. 10, 2019

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...